Search
Sellas Life Sciences Group Inc
SLSAdd to Watchlist
8.420USD
+0.540+6.85%
Close 11-06 16:00（ET）
1.70BMarket Cap
LossP/E TTM
After-hours 19:57 (ET)8.360USD-0.020-0.24%
After-hours 19:57 (ET)Sellas Life Sciences Group Inc (SLS) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Sellas Life Sciences Group Inc in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
32.500USD+235.74%
SLS Analyst Recommendation Trends
In the current month, SLS has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SLS average Analyst price target in the last month is 32.500.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
1
1
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
3
3
SLS Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Biontech SE
BNTX
4
12
6
0
0
22
IQVIA Holdings Inc
IQV
8
13
1
0
0
22
Financial Forecasting
Based on analysts' estimates, SLS EPS is projected to reach -0.050 in FY2026Q3, following reported EPS of -0.051 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.07
-0.04
-0.04
-0.05
-0.05
Actual
-0.05
-0.05
-0.05
--
--
Surprise
+16.60%
-21.85%
-12.82%
--
--
FAQs
What is Sellas Life Sciences Group Inc's price target?
Analysts forecast that Sellas Life Sciences Group Inc's price target is USD 32.50, with the highest forecast at USD 35.00 and the lowest forecast at USD 30.00.
How have Sellas Life Sciences Group IncSLS's recent earnings per share performed?
The market expectation was USD -0.05, while Sellas Life Sciences Group IncSLS's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD -0.05.
What is the analyst rating for Sellas Life Sciences Group Inc?
Based on the ratings of Sellas Life Sciences Group Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.